3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
19
Carcinoma, Non-Small-Cell Lung
9
Rhabdomyosarcoma
6
Triple Negative Breast Neoplasms
5
Hodgkin Disease
4
Recurrence
3
Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Rhabdomyosarcoma, Embryonal
2
Rhabdomyosarcoma, Alveolar
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Adenocarcinoma
2
Solitary Fibrous Tumor, Pleural
1
NSCLC
1
Metastatic HER2-positive Breast Cancer
1
Mesothelioma, Malignant
1
Lung Diseases, Interstitial
1
Locally Advanced Non-Small Cell Lung Cancer
1
HR+HER2- Breast Cancer
1
Fludzoparib" and Anti-angiogenic
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Large Cell
1
Advanced Breast Cancer
1
Interventions
Temozolomide
12
Vincristine
9
Irinotecan
8
Cyclophosphamide
8
cabozantinib
6
X-Rays
5
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Etoposide
5
regorafenib
4
fludarabine
4
Radiotherapy
4
Phantoms, Imaging
4
Ifosfamide
4
Doxorubicin
4
Radiation
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
liposomal doxorubicin
2
ivosidenib
2
irinotecan sucrosofate
2
etoposide phosphate
2
abemaciclib
2
Zoledronic Acid
2
Topotecan
2
Surgical Procedures, Operative
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
Vinorelbine
×
1 year
×
Clear all
No trials found.